2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
88
Colonic Neoplasms
30
Colonic Polyps
20
Adenoma
19
Polyps
8
Neoplasms
8
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Adenomatous Polyps
6
Disease
5
Rectal Neoplasms
4
Pain
4
Gastrointestinal Neoplasms
4
Stomach Neoplasms
2
Peptic Ulcer
2
Pancreatic Neoplasms
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Diseases
1
Interventions
Irinotecan
4
Bevacizumab
3
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Drug Therapy
2
Cyclophosphamide
2
Cetuximab
2
Capecitabine
2
pembrolizumab
1
napabucasin
1
guadecitabine
1
encorafenib
1
Sutures
1
Surgical Instruments
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Leukocyte Immunoglobulin-like Receptor B1
1
KRN-330
1
Drainage
1
Colonoscopy
1
Chemoradiotherapy
1
Aspirin
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Diseases
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled